Healthcare Equipment and Supplies
Company Overview of ACell, Inc.
ACell, Inc. engages in the development and commercialization of extracellular matrix devices to repair and remodel damaged tissues and organs in a range of surgical procedures for the U.S. and international patents. It offers MatriStem technology, a non-crosslinked, resorbable, and acellular material; MatriStem Wound Care Matrix, a wound care device with regenerative medicine technology; MatriStem Plastic Surgery Matrix, a plastic surgery and wound care device; and MatriStem Hernia Matrix, a general surgery device. The company was incorporated in 1999 and is headquartered in Columbia, Maryland. It has a manufacturing facility in Lafayette, Indiana.
6640 Eli Whitney Drive
Columbia, MD 21046
Founded in 1999
Key Executives for ACell, Inc.
Chief Executive Officer, Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
Vice President of Operations
Senior Vice President and General Counsel
Compensation as of Fiscal Year 2015.
ACell, Inc. Key Developments
ACell, Inc. Announces Release of MatriStem Surgical Matrix Plus
May 28 15
ACell, Inc. announced the release of MatriStem Surgical Matrix Plus, which is indicated for use in a range of surgical procedures including tissue repair, body wall repair, and hernia repair at the American Society of Colon and Rectal Surgeons (ASCRS) Annual Scientific Meeting. The product was designed to provide the strength and support needed in abdominal wall procedures, while also offering superior handling. Its reduced preparation time can also increase operating room efficiency, while its optimal and conformability make it suitable for increasingly common minimally invasive procedures. Surgical Matrix Plus will be featured in the ASCRS New Technologies Symposium, a showcase for innovative products. MatriStem Surgical Matrix Plus will be available in four sizes, and is part of the MatriStem Surgical Matrix product family, which includes Surgical Matrix RS, PSM, PSMX.
ACell, Inc. Appoints David Elliot as Vice President, Marketing
Mar 16 15
ACell, Inc. announced the selection of David Elliot as Vice President, Marketing. In this role, Elliot will lead all ACell marketing initiatives and offer strategic direction to advance ACell as a leading regenerative medicine company. Elliot previously served as Vice President, Academic Affairs and Marketing Services at St. Jude Medical.
ACell, Inc. Appoints Thomas Gilbert as a Chief Science Officer
Jan 5 15
ACell, Inc. announced that it has appointed Thomas Gilbert as a Chief Science Officer. Dr. Gilbert has served as Vice President, Research and Development at ACell since 2012. In his new position, Dr. Gilbert will add oversight of Clinical Research programs to his Research and Development responsibilities, with the goal of building a unified product development strategy from initial concept to post-market clinical evaluation. Dr. Gilbert previously served as Assistant Professor of Surgery, Cardiothoracic Surgery and Bioengineering at the University of Pittsburgh and was a faculty member of the McGowan Institute for Regenerative Medicine.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|